Tirzepatide injection site reactions: 5 patterns
About 5-15% of tirzepatide patients develop some form of local reaction. Most are minor; the few that aren't follow a predictable pattern.
The mechanism
Subcutaneous injection of any peptide formulation can produce local reactions. Tirzepatide formulations include excipients (buffers, preservatives, stabilizers) that can sensitize the skin in a small minority of patients. Cold-injected pen produces more local discomfort than room-temperature pen because the cold liquid stings more on injection.
What to expect
Most reactions are minor (mild redness lasting 24-48 hours) and resolve without intervention. About 1-3% of patients have more substantial reactions (hive-like welts, persistent firm lumps, or delayed-onset reactions). Most patterns are reproducible: the same site type, same approximate size each injection.
Management
Pattern 1 (mild local irritation): nothing required; OTC hydrocortisone if itchy. Pattern 2 (persistent firm lump): switch injection regions for 6-8 weeks. Pattern 3 (urticarial reaction): pre-treat with cetirizine 10mg or loratadine 10mg 30-60 min before injection; topical hydrocortisone after. Pattern 4 (delayed-onset, 12-72 hours after): document and discuss with prescriber. Pattern 5 (suspected infection: increasing redness/warmth/pus 24-48 hours after, possibly with fever): seek medical attention. Prevention: room-temperature pen (30-45 min out of fridge), site rotation across four-quadrant abdominal pattern, perpendicular injection angle, full 10-second hold.
When to escalate
Reactions extending more than 5cm from injection point. Any systemic symptoms (facial swelling, breathing difficulty, fever). Reactions that worsen 24-48 hours after injection (suggests infection or delayed hypersensitivity).
- SURMOUNT-1 (Jastreboff et al., NEJM 2022)